<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28490" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Rett Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chahil</surname>
            <given-names>Gurneet</given-names>
          </name>
          <aff>University of Missouri</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bollu</surname>
            <given-names>Pradeep C.</given-names>
          </name>
          <aff>University of Missouri</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Gurneet Chahil declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pradeep Bollu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28490.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Rett syndrome (RTT) is a neurodevelopmental disorder that should be considered in a child who demonstrates regression in previously acquired skills after a period of normal development. RTT can present with a broad array of symptoms. A few of these include deceleration in head growth, gait abnormalities, loss of purposeful hand movements, which are often replaced with repetitive stereotypical movements such as hand-wringing, loss of speech and breathing abnormalities. Although RTT was once thought to occur exclusively in females, males with the phenotype and MECP2 mutations are now being defined. This activity describes the evaluation, diagnosis, and management of Rett syndrome and stresses the role of team-based interprofessional care for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe patient history clues that might lead to consideration of Rett Syndrome.</p></list-item><list-item><p>Review how to evaluate for Rett syndrome.</p></list-item><list-item><p>Identify treatment considerations for patients with Rett Syndrome.</p></list-item><list-item><p>Explain the role of interprofessional team members in optimizing collaboration and communication to ensure patients with Rett syndrome receive high-quality care, which will lead to enhanced outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28490&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28490">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28490.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Rett syndrome (RTT) is a neurodevelopmental disorder in which regression of previously acquired skills follows a period of typical development. RTT can present with a multitude of symptoms including but not limited to a deceleration in head growth, gait abnormalities, loss of purposeful hand movements often replaced with repetitive stereotypical movement (hand-wringing), loss of speech and breathing abnormalities. RTT is associated with a complex phenotype and has been classified into typical, atypical, and variant presentations.&#x000a0; Approximately 90% of reported cases of RTT inherit mutations of the methyl-CpG-binding protein 2 (<italic toggle="yes">MECP2</italic>) gene. Some atypical cases of RTT may result from mutations in cyclin-dependent kinase-like 5 (<italic toggle="yes">CDKL5</italic>). Mutations in <italic toggle="yes">MECP2</italic> have been associated with impacting the development of neurons and axodendritic connections. Jellinger and Seitelberger (1986) were the first neuropathologists to identify and describe the pathology behind RTT. They found that the brain in patients of RTT weighed less, and the neurons of the substantia nigra pars compacta contained less melanin in comparison to the age-matched controls. Although RTT was thought to be exclusive to females, males with the phenotype and <italic toggle="yes">MECP2</italic> mutations are now being defined.<xref ref-type="bibr" rid="article-28490.r1">[1]</xref><xref ref-type="bibr" rid="article-28490.r2">[2]</xref><xref ref-type="bibr" rid="article-28490.r3">[3]</xref></p>
      </sec>
      <sec id="article-28490.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>RTT is an X-linked dominant condition with lethal consequences in hemizygous males. Mutations in <italic toggle="yes">MECP2</italic> are found in the majority of classic RTT cases; recent studies found 2 additional genes, cyclin-dependent kinase-like 5 (<italic toggle="yes">CDKL5</italic>) and forkhead box G1 (<italic toggle="yes">FOXG1</italic>) involved in the pathogenesis of RTT. The spectrum of mutation types includes missense, nonsense, and frameshift mutations. <xref ref-type="bibr" rid="article-28490.r4">[4]</xref><xref ref-type="bibr" rid="article-28490.r5">[5]</xref>Mutations affecting the NLS region of <italic toggle="yes">MECP2</italic> or early truncating mutations are responsible for a more severe phenotype in comparison to missense mutations, whereas C-terminal deletions are associated with milder phenotypes. The R133C mutation is generally associated with a milder variant of RTT often with preserved speech. The MECP2 protein is responsible for 2 main functioning roles: the methyl-binding domain, which specifically binds to the methylated CpG dinucleotides, and the transcription repression domain, which recruits repressor proteins that inhibit gene transcription. Mutations in an X-linked gene <italic toggle="yes">CDKL5</italic> have been reported in patients with a seizure variant of RTT. It is important to note that there is&#x000a0;a wide spectrum of mutations associated with disease severity and close to 30 different types mutations can cause RTT.<xref ref-type="bibr" rid="article-28490.r6">[6]</xref></p>
      </sec>
      <sec id="article-28490.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>RTT is one of the most frequent causes of mental disability in females, with an incidence of 1 in 10,000 to 15, 000. A population-based registry in Texas reported a prevalence of classic RTT as 1 per 22,800 females (0.44 per 10,000) from ages 2 to 18. RTT was originally thought to only occur in females and males with RTT were not considered to be viable.&#x000a0; Further investigations on the incidence and prevalence of RTT in males&#x000a0;are needed. A systematic review conducted in Texas in 2015 reported a total of 57 cases of RTT in males and a population study showed the incidence of RTT in males was not more predominant in any particular race.<xref ref-type="bibr" rid="article-28490.r7">[7]</xref></p>
      </sec>
      <sec id="article-28490.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Approximately 95% of RTT is the due to <italic toggle="yes">MECP2</italic> mutations in the region of the gene methyl CpG-binding protein. Recent studies suggest <italic toggle="yes">MECP2</italic> has both repressor and activator transcription activities. The exact mechanism of how <italic toggle="yes">MECP2</italic> mutations lead to RTT is not yet known. A possible theory is that a deficiency of <italic toggle="yes">MECP2</italic> causes an inability of synaptic maturation in the cortex. Another hypothesis is the lack of <italic toggle="yes">MECP2</italic> disrupts the metabolism of brain cholesterol resulting in abnormal neuronal development. There have also been studies suggesting the failure of dendritic arborization in the cortex has led to abnormal neuronal signaling resulting in&#x000a0;the lack of maturation of the autonomic nervous system, along with the motor and cortical regions. Recent evidence suggests that <italic toggle="yes">MECP2</italic> is also expressed in glial cells and glial cell dysfunction caused by a change in DNA methylation could also be involved in the pathogenesis of RTT.</p>
      </sec>
      <sec id="article-28490.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>On autopsy, an RTT brain does not show signs of inflammation or degeneration. However, there is an overall decrease in the size of the brain and individual neurons. A 12% to 34% reduction in brain weight has been reported, most prominent in the prefrontal, posterior frontal and anterior frontal regions. These findings suggest that RTT is a neurodevelopmental and not a neurodegenerative process. The neuronal cell size is decreased, but there is an increase in neuronal cell packing in the hippocampus along with delayed neuronal maturation and synaptogenesis in the cerebral cortex.</p>
      </sec>
      <sec id="article-28490.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p><italic toggle="yes">MECP2</italic>&#x000a0;mutations alone are not enough to make a diagnosis of RTT. RTT is still considered a clinical diagnosis and is divided into typical and atypical presentations. The diagnostic criteria for a typical presentation require the presence of regression in addition to the criteria mentioned above main criteria plus the exclusion criteria must be met (see Table 1). In typical RTT, there will be a regression of purposeful hand use and spoken language resulting in a hand-wringing movement and abnormal gait. A stage of stabilization will often follow regression, and sometimes there will even be an improvement. Not all individuals with typical RTT will have postnatal deceleration in head growth. The diagnostic criteria for atypical RTT require the presence of regression plus 2 out of the 4 main criteria in addition to 5 out of the 11 supportive criteria (see Table 2). The above-mentioned criteria for typical RTT and atypical RTT apply to both males and females.<xref ref-type="bibr" rid="article-28490.r8">[8]</xref><xref ref-type="bibr" rid="article-28490.r9">[9]</xref><xref ref-type="bibr" rid="article-28490.r10">[10]</xref></p>
      </sec>
      <sec id="article-28490.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Currently, there is no cure for RTT, and medical management is aimed to provide symptomatic relief for patients through a multidisciplinary approach. Some of the medical concerns that need to be addressed in RTT patients include seizure disorders, behavioral alterations, sleep disorders, breathing irregularities, cardiac dysfunction (prolonged QT interval), gastrointestinal dysfunction and bone fractures. Approximately 60% of patients with RTT suffer from some seizure disorder. Treatment options to alleviate seizures include valproate, lamotrigine, levetiracetam carbamazepine, and AEDs. Behavioral alterations most often anxiety can be best addressed with serotonin reuptake inhibitors (SSRIs). RTT patients often have difficulty initiating sleep and frequent nighttime awakening, which can be managed with proper sleep hygiene and trazodone once airway obstructions and other causes are ruled out. Breathing irregularities can include, apnea, hyperventilation, and breath holding. Successful management of these irregularities can be difficult. However, precautions should be taken to avoid medications that alter breathing patterns, for example, opioid medications. Cardiac irregularities include a prolonged QT interval. This can be more difficult to manage in patients with RTT compared to the general population. Studies in mice with <italic toggle="yes">MECP2</italic> mutations suggest that beta blockers may not be sufficient. Precautions should be taken to avoid medications that would further prolong the QT interval, for example, macrolides. Bone fractures are 4 times more common in RTT patients compared to the general population, and vitamin D levels should be closely monitored and supplemented as required. Digestive problems such as gastroesophageal reflux disease (GERD) and constipation are common in RTT patients and can be managed with calcium carbonate, histamine H2 receptor blockers (avoid cimetidine), and&#x000a0;an increase in fiber intake. Other treatment options include physical therapy, speech therapy, occupational therapy, and psychosocial support for families. Management of these conditions can substantially improve the quality of life of RTT patients and should not be overlooked.<xref ref-type="bibr" rid="article-28490.r11">[11]</xref><xref ref-type="bibr" rid="article-28490.r12">[12]</xref><xref ref-type="bibr" rid="article-28490.r13">[13]</xref><xref ref-type="bibr" rid="article-28490.r14">[14]</xref></p>
      </sec>
      <sec id="article-28490.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>RTT can often be misdiagnosed. Important differential diagnoses to consider are cerebral palsy, autism, Angelman syndrome, and non-specific developmental delay.</p>
      </sec>
      <sec id="article-28490.s10" sec-type="Staging">
        <title>Staging</title>
        <p>Before the RTT criteria revisions and the discovery of <italic toggle="yes">MECP2,</italic> a staging system was implemented as a guide for clinicians to track the clinical course of RTT. It is important to note that the staging system does not predict life expectancy and should not be used for diagnostic purposes. Stage 1 begins around 6 to 18 months and involves developmental arrest. Some signs include limited eye contact, deceleration of head growth, non-specific hand-wringing and gross motor delays. Stage 2 onset is between the ages of 1 to 4 and consists of regression and rapid deterioration. Stage 2 is characterized by stereotypic hand movement (hand-wringing or washing), loss of speech, irritability and disturbed sleep. Stage 3 onset is between the ages of 2 to 10 is characterized by improvement in behavior, communication skills, and hand use. Stage 4 onset is after the age of 10 years and is characterized by dystonia, reduced mobility, and bradykinesia.</p>
      </sec>
      <sec id="article-28490.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The life expectancy of an induvial with RTT can vary depending on the type of MECP2 mutation inherited [20]. Typically RTT individuals survive into middle age and recent studies suggest they may survive longer.</p>
      </sec>
      <sec id="article-28490.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and management of RETT syndrome ie very difficult. The disorder is best managed by an interprofessional team.</p>
        <p>Currently, there is no cure for RTT, and medical management is aimed to provide symptomatic relief for patients through an interprofessional approach. Some of the medical concerns that need to be addressed in RTT patients include seizure disorders, behavioral alterations, sleep disorders, breathing irregularities, cardiac dysfunction (prolonged QT interval), gastrointestinal dysfunction and bone fractures. Approximately 60% of patients with RTT suffer from some seizure disorder.</p>
        <p>The outlook for patients with RETT syndrome is guarded. Most have a reduced life span and a poor quality of life.<xref ref-type="bibr" rid="article-28490.r15">[15]</xref>&#x000a0;(Level V)</p>
      </sec>
      <sec id="article-28490.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28490&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28490">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/rett-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28490">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28490/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28490">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-28490.s14">
        <fig id="article-28490.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Rett Syndrome tables Contributed by Gurneet Chahil</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="RTT__Tables" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-28490.s15">
        <title>References</title>
        <ref id="article-28490.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Operto</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Mazza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pastorino</surname>
                <given-names>GMG</given-names>
              </name>
              <name>
                <surname>Verrotti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Coppola</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Epilepsy and genetic in Rett syndrome: A review.</article-title>
            <source>Brain Behav</source>
            <year>2019</year>
            <month>May</month>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>e01250</fpage>
            <pub-id pub-id-type="pmid">30929312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;nez-Rodr&#x000ed;guez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n-S&#x000e1;nchez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Coviello</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Foiani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kul</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stork</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Garc&#x000ed;a</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nacher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lanuza</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Agust&#x000ed;n-Pav&#x000f3;n</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Lack of MeCP2 leads to region-specific increase of doublecortin in the olfactory system.</article-title>
            <source>Brain Struct Funct</source>
            <year>2019</year>
            <month>May</month>
            <volume>224</volume>
            <issue>4</issue>
            <fpage>1647</fpage>
            <page-range>1647-1658</page-range>
            <pub-id pub-id-type="pmid">30923887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ehrhart</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Coort</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Eijssen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cirillo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Smeets</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Bahram Sangani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Evelo</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Curfs</surname>
                <given-names>LMG</given-names>
              </name>
            </person-group>
            <article-title>Integrated analysis of human transcriptome data for Rett syndrome finds a network of involved genes.</article-title>
            <source>World J Biol Psychiatry</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>21</volume>
            <issue>10</issue>
            <fpage>712</fpage>
            <page-range>712-725</page-range>
            <pub-id pub-id-type="pmid">30907210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Einspieler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Marschik</surname>
                <given-names>PB</given-names>
              </name>
            </person-group>
            <article-title>Regression in Rett syndrome: Developmental pathways to its onset.</article-title>
            <source>Neurosci Biobehav Rev</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>98</volume>
            <fpage>320</fpage>
            <page-range>320-332</page-range>
            <pub-id pub-id-type="pmid">30832924</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Banerjee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sur</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kaufmann</surname>
                <given-names>WE</given-names>
              </name>
            </person-group>
            <article-title>Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder.</article-title>
            <source>Brain</source>
            <year>2019</year>
            <month>Feb</month>
            <day>01</day>
            <volume>142</volume>
            <issue>2</issue>
            <fpage>239</fpage>
            <page-range>239-248</page-range>
            <pub-id pub-id-type="pmid">30649225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Justice</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Treating Rett syndrome: from mouse models to human therapies.</article-title>
            <source>Mamm Genome</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>30</volume>
            <issue>5-6</issue>
            <fpage>90</fpage>
            <page-range>90-110</page-range>
            <pub-id pub-id-type="pmid">30820643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gold</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Krishnarajy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ellaway</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Christodoulou</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Rett Syndrome: A Genetic Update and Clinical Review Focusing on Comorbidities.</article-title>
            <source>ACS Chem Neurosci</source>
            <year>2018</year>
            <month>Feb</month>
            <day>21</day>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>167</fpage>
            <page-range>167-176</page-range>
            <pub-id pub-id-type="pmid">29185709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neul</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Benke</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Marsh</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Skinner</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Merritt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lieberman</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Standridge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Feyma</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Heydemann</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ryther</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suter</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kaufmann</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Glaze</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Percy</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2.</article-title>
            <source>Am J Med Genet B Neuropsychiatr Genet</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>180</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-67</page-range>
            <pub-id pub-id-type="pmid">30536762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zengin-Akku&#x0015f;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ta&#x0015f;k&#x00131;ran</surname>
                <given-names>EZ</given-names>
              </name>
              <name>
                <surname>Kaba&#x000e7;am</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>&#x0015e;im&#x0015f;ek-Kiper</surname>
                <given-names>P&#x000d6;</given-names>
              </name>
              <name>
                <surname>Halilo&#x0011f;lu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Boduro&#x0011f;lu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Utine</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Clinical and molecular evaluation of 16 patients with Rett syndrome.</article-title>
            <source>Turk J Pediatr</source>
            <year>2018</year>
            <volume>60</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">30102473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sch&#x000f6;newolf-Greulich</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bisgaard</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>M&#x000f8;ller</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Dun&#x000f8;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Br&#x000f8;ndum-Nielsen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Van Bergen</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Lunke</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eggers</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jespersgaard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Christodoulou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>T&#x000fc;mer</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Clinician's guide to genes associated with Rett-like phenotypes-Investigation of a Danish cohort and review of the literature.</article-title>
            <source>Clin Genet</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>95</volume>
            <issue>2</issue>
            <fpage>221</fpage>
            <page-range>221-230</page-range>
            <pub-id pub-id-type="pmid">29023665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sadeghi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shevell</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Consideration of Genetic Diagnoses of Developmental Delay in Children of Consanguineous Families.</article-title>
            <source>Semin Pediatr Neurol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>26</volume>
            <fpage>60</fpage>
            <page-range>60-62</page-range>
            <pub-id pub-id-type="pmid">29961522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jefferson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leonard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Siafarikas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Woodhead</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fyfe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Munns</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Motil</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tarquinio</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Brismar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ben-Zeev</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bisgaard</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Coppola</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ellaway</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Freilinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Geerts</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Humphreys</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Larsson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lotan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Percy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pineda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Skinner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Syhler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Witt Engerstr&#x000f6;m</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Downs</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Clinical Guidelines for Management of Bone Health in Rett Syndrome Based on Expert Consensus and Available Evidence.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>e0146824</fpage>
            <pub-id pub-id-type="pmid">26849438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leonard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ravikumara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baikie</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Naseem</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ellaway</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Percy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Geerts</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bathgate</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Downs</surname>
                <given-names>J</given-names>
              </name>
              <collab>Telethon Institute for Child Health Research</collab>
            </person-group>
            <article-title>Assessment and management of nutrition and growth in Rett syndrome.</article-title>
            <source>J Pediatr Gastroenterol Nutr</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>451</fpage>
            <page-range>451-60</page-range>
            <pub-id pub-id-type="pmid">24084372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vignoli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>La Briola</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Peron</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Savini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cogliati</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Canevini</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Medical care of adolescents and women with Rett syndrome: an Italian study.</article-title>
            <source>Am J Med Genet A</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>158A</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-8</page-range>
            <pub-id pub-id-type="pmid">22139899</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28490.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palacios-Ce&#x000f1;a</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Famoso-P&#x000e9;rez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Salom-Moreno</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Carrasco-Garrido</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Corrales</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Paras-Bravo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>G&#x000fc;eita-Rodriguez</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>"Living an Obstacle Course": A Qualitative Study Examining the Experiences of Caregivers of Children with Rett Syndrome.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2018</year>
            <month>Dec</month>
            <day>25</day>
            <volume>16</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30585176</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
